NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be ...
Creator Zack Gilligan, the clever mind that brought us "Breaking Bad" and "Better Call Saul," has blessed sci-fi lovers with ...
As Delhi-NCR battles severe pollution, we list 5 best alternatives of Dyson air purifiers to consider in 2025, helping you ...
SHELTON, CONNECTICUT / ACCESS Newswire / November 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), today announced that it has entered into a securities purchase agreement with a ...
The FDA’s Marty Makary and Vinay Prasad have laid out a path for CRISPR treatments on demand. An expert weighs in on what it ...
Received FDA IND clearance to evaluate CDI-988 as both norovirus preventive and treatmentExpects to initiate CDI-988 Phase 1b ...
Pharmaceutical Technology on MSN
MSD bets big on flu antivirals with $9.2bn buyout of Cidara
MSD has now agreed two deals around the $10bn mark in 2025 as it looks to shore up its pipeline with Keytruda’s looming ...
Presented new data at the Society of Immunotherapy for Cancer (SITC) annual meeting on CLD-401 protection from immune clearance after systemic administration; data also demonstrates that the platform ...
The Allahabad High Court refused bail to an accused in a cyber fraud case involving fake GST registrations, citing strong evidence and the rising threat of digital ...
The battle against HIV in sub-Saharan Africa has always been as much about systems and science as about the virus itself. Antiretroviral therapy has turned what was once a death sentence into a ...
It’s the thesis of Pluribus episode 3, which further explores how bizarre humanity’s new collective hive mind operates.
Yoshua Bengio, considered by many to be one of the godfathers of AI, has long been at the forefront of machine-learning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results